The following content is translated from Chinese source by machine translation without post-editing.
MicroPort was established in 1998 and is an innovative high-end medical device group. In May 2023, TalkingChina established a translation cooperation relationship with MicroPort Instrument Co., Ltd. to provide translation services for professional medical training materials on heart valve content. MicroPort is a listed company in Hong Kong. Its products have entered more than 20000 hospitals in more than 100 countries around the world. On average, one MicroPort product is used every 6 seconds worldwide to save the lives of patients or improve their quality of life or help them to hasten the birth of new lives.
The MicroPort coronary drug stent product is the first domestic drug stent system. Since it was launched in 2004, it has maintained its leading market share in the domestic market. The first drug targeted eluting stent system launched in 2014 makes MicroPort achieve a leap from follower to leader in the coronary stent field. In the field of orthopaedic joints, the market share of MicroPort currently ranks fourth in the world. MicroPort focuses on independent innovation, has more than 1600 patents (applications), and many products have won the second prize of National Science and Technology Progress Award and other national, provincial and ministerial honors. Through overseas mergers and acquisitions and joint ventures, MicroPort is also gradually promoting the global industrial layout. As a leading translation service provider in the pharmaceutical and medical industry, TalkingChina has a professional translation team covering 61 languages around the world with Anglo Japanese and German as the core. It has long maintained good cooperative relations with major medical devices and biomedical companies, and its cooperative customers include but are not limited to Sartorius, Eppendorf AG, EziSurg Medical, Charles River, Avantor, CSPC, etc. In the future cooperation with MicroPort, TalkingChina will also continue to provide high-quality translation services and provide language support for the development of customers’ global business.
Post time: Jul-27-2023